Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Share Price, Comparison and Key Differences
- August 11, 2026
- Posted by: Neeraj Pandey
- Category: News
Healthcare Global Enterprises MCap Rs 10,091 Cr, PE 303.07x (thin earnings), ROE 2.90%, D/E 1.30. Yatharth Hospital and Trauma Care Services MCap Rs 8,385 Cr, PE 49.25x, ROE 9.85%.
Healthcare Global Enterprises (HCG) vs Yatharth Hospital and Trauma Care Services is a comparison hospital chain investors look up when evaluating two listed Indian hospital companies with different specialisations. HCG (Healthcare Global Enterprises), a Bengaluru-based company backed by CVC Capital Partners, operates India’s largest network of comprehensive cancer care (oncology) hospitals under HCG brand. Yatharth Hospital and Trauma Care Services, a Noida-based company that listed in 2023, operates multispecialty hospitals with a focus on trauma care and tertiary medical services in the Delhi-NCR and Uttar Pradesh region.
This Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services article covers reach and market position, key products, latest declared results and stock valuation. The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services data below is sourced from Groww and public company filings and reflects the most recently available information at the time of writing.
Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Reach and Market Position
On the Healthcare Global Enterprises side of the Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services comparison, HCG operates 22+ comprehensive cancer care centres across India, providing radiation, medical and surgical oncology. Market capitalisation is Rs 10,091 Cr.
Click Here – Get Free Investment Predictions
On the Yatharth Hospital and Trauma Care Services side of the Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services comparison, Yatharth Hospital operates multispecialty tertiary hospitals in Noida, Greater Noida and Faridabad. Market capitalisation is Rs 8,385 Cr.
Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Key Products and Business Mix
In the Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services product comparison, Healthcare Global Enterprises offers: HCG earns from oncology treatments – radiation therapy, chemotherapy, surgery, bone marrow transplants and palliative care. EPS is Rs 2.23. PE is 303.07x (very thin earnings – oncology infrastructure costs drag current profitability). ROE is 2.90 percent, D/E 1.30.
For Yatharth Hospital and Trauma Care Services in this Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services breakdown: Yatharth Hospital earns from multispecialty hospital services – trauma surgery, cardiology, orthopaedics and general surgery. EPS is Rs 17.67. PE is 49.25x, ROE 9.85 percent, D/E 0.15.
Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Latest Results
The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services results for Healthcare Global Enterprises: HCG has a market cap of Rs 10,091 Cr and PE of 303.07x. ROE is 2.90 percent. HCG’s oncology network requires significant radiation equipment and facility investment before reaching profitability at each centre. HCG is marginally larger than Yatharth.
The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services results for Yatharth Hospital and Trauma Care Services: Yatharth Hospital has a market cap of Rs 8,385 Cr and PE of 49.25x. ROE is 9.85 percent. Yatharth is profitable with a much healthier ROE and lower PE than HCG. Yatharth listed in 2023 and is growing its NCR hospital network.
Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Stock and Valuation
The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services stock comparison uses the latest available market data from Groww. Investors tracking Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services should verify current prices on NSE or BSE before trading.
HCG vs Yatharth Hospital at current valuations: HCG trades at Rs 10,091 Cr market cap, PE 303.07x (thin earnings), ROE 2.90 percent. Yatharth trades at Rs 8,385 Cr market cap, PE 49.25x, ROE 9.85 percent. Yatharth is substantially cheaper on PE with a much higher ROE. HCG is an oncology specialist whose PE is distorted by thin earnings.
Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services: Quick Comparison Table
The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services comparison table below summarises the key metrics covered in this article side by side.
| Parameter | Healthcare Global Enterprises | Yatharth Hospital and Trauma Care Services |
|---|---|---|
| Sector | Comprehensive oncology (cancer care): 22+ HCG centres pan-India | Multispecialty hospitals: trauma, cardiology, ortho (NCR + UP) |
| Market Cap | Rs 10,091 Cr | Rs 8,385 Cr |
| P/E Ratio | 303.07x (thin earnings) | 49.25x |
| ROE | 2.90% | 9.85% |
| Debt to Equity | 1.30 | 0.15 |
| Specialisation | Pure oncology (cancer care network) | Multispecialty tertiary with trauma focus |
| Private Equity Backer | CVC Capital Partners | None (promoter-owned) |
Conclusion
The Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services comparison above covers the key data points on reach, products, results and valuation. Healthcare Global Enterprises vs Yatharth Hospital covers oncology specialist hospitals versus multispecialty trauma care. HCG has a unique pan-India cancer care network but its PE is very high due to thin earnings from heavy capex. Yatharth is a profitable, growing NCR multispecialty hospital with healthier near-term financial metrics. HCG vs Yatharth investors should review bed utilisation, ARPOB (Average Revenue Per Occupied Bed), new hospital openings and cancer care volumes. Consult a SEBI-registered advisor for personalised guidance. Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services investors should track bed addition pace and payor mix. Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services are both in the growing private hospital segment. Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services investors should track bed utilisation data in quarterly results. Healthcare Global Enterprises vs Yatharth Hospital and Trauma Care Services are both growing private hospital companies in different healthcare specialities. Consult a SEBI-registered advisor for personalised guidance.
Download the Univest iOS App or Univest Android App to track Healthcare Global Enterprises and Yatharth Hospital and Trauma Care Services live price and get daily stock recommendations.
Disclaimer: Data and figures in this article are sourced from publicly available information, including company results filings and exchange data, and are current as of the time of writing. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).
Frequently Asked Questions
What is HCG Healthcare Global?
Ans. HCG (Healthcare Global Enterprises) operates India’s largest network of comprehensive cancer (oncology) care centres. HCG centres provide radiation oncology, medical oncology, surgical oncology, bone marrow transplantation and palliative care.
What is Yatharth Hospital?
Ans. Yatharth Hospital and Trauma Care Services operates multispecialty tertiary hospitals in the Delhi-NCR region (Noida, Greater Noida, Faridabad) providing trauma surgery, cardiology, neurosciences, orthopaedics and general surgical services.
Why is HCG PE so high?
Ans. HCG’s PE of 303x reflects thin current earnings due to heavy capital investment in radiation equipment (linear accelerators, proton therapy) and hospital infrastructure for its cancer centre expansion. Each new centre requires years to reach profitability.
What is ARPOB in hospitals?
Ans. ARPOB (Average Revenue Per Occupied Bed) is a key hospital efficiency metric measuring revenue generated per occupied bed per day. Higher ARPOB reflects premium pricing, favourable case mix or higher value surgical and medical procedures.
Is HCG profitable?
Ans. HCG is technically profitable but with very thin margins resulting in a PE of 303x. The company’s oncology network requires sustained investment before all centres reach optimal capacity.
Are HCG and Yatharth in Nifty 50?
Ans. Neither is in Nifty 50. Both are tracked in smaller indices.
Which is larger, HCG or Yatharth?
Ans. HCG at Rs 10,091 Cr is approximately 1.2 times larger than Yatharth Hospital at Rs 8,385 Cr.
